ScholarLens Back to search
2004•Medical Journal of Chinese People HeacthRequires access

A comparative study of mirtazapine and maprotiline in the treatment of treatment - resistant depression

Din Guo

Open publisher page 0 citations

Abstract

Objective: To evaluate the efficacy and side effects of mirtazapine and maprotiline in the treatment of treatment - resistant depression (TRsD). Methods: The patients were randomly assigned into mirtazapine group and maprotiline group (control group). The efficacy and side effects were assessed with Hamilton depression scale (HAMD), Hamilton anxiety scale (HAMA), clinical global impression (CGI - SI) and the treatment emergent scale (TESS) before and after 1,2,4,6 weeks treatment respectively. Results: In mirtazapine group, the HAMD and HAMA scores decreased from 31. 5 to 17.2 and from 24. 7 to 14.4. And they decreased from 32.2 to 22.7 and from 26.9 to 21.5 in maprotiline group. The cases improved were respectively 12 and 4 in the two groups. Mirtazapine was more effective and had fewer side effects than Maprotiline in the treatment. Conclusions: The curative effect of Mirtazapine is better than that of Maprotiline in the treatment of treatment - resistant depression.

About this research paper

What this paper is about

Objective: To evaluate the efficacy and side effects of mirtazapine and maprotiline in the treatment of treatment - resistant depression (TRsD). Methods: The patients were randomly assigned into mirtazapine group and maprotiline group (control group). The efficacy and side effects were assessed with Hamilton depression scale (HAMD), Hamilton anxiety scale (HAMA), clinical global impression (CGI - SI) and the treatment emergent scale (TESS) before and after 1,2,4,6 weeks treatment respectively. Results: In mirtazapine group, the HAMD and HAMA scores decreased from 31. 5 to 17.2 and from 24. 7 to 14.4. And they decreased from 32.2 to 22.7 and from 26.9 to 21.5 in maprotiline group. The cases improved were respectively 12 and 4 in the two groups. Mirtazapine was more effective and had fewer side effects than Maprotiline in the treatment. Conclusions: The curative effect of Mirtazapine is better than that of Maprotiline in the treatment of treatment - resistant depression.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective: To evaluate the efficacy and side effects of mirtazapine and maprotiline in the treatment of treatment - resistant depression (TRsD). Methods: The patients were randomly assigned into mirtazapine group and maprotiline group (control group). The efficacy and side effects were assessed with Hamilton depression scale (HAMD), Hamilton anxiety scale (HAMA), clinical global impression (CGI - SI) and the treatment emergent scale (TESS) before and after 1,2,4,6 weeks treatment respectively. Results: In mirtazapine group, the HAMD and HAMA scores decreased from 31. 5 to 17.2 and from 24. 7 to 14.4. And they decreased from 32.2 to 22.7 and from 26.9 to 21.5 in maprotiline group. The cases improved were respectively 12 and 4 in the two groups. Mirtazapine was more effective and had fewer side effects than Maprotiline in the treatment. Conclusions: The curative effect of Mirtazapine is better than that of Maprotiline in the treatment of treatment - resistant depression.

Key concepts: Maprotiline, Mirtazapine, Hamd, Clinical Global Impression, Depression (economics), Hamilton depression scale, Side effect (computer science), Psychology

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
A comparative study of mirtazapine and maprotiline in the treatment of treatment - resistant depression — Research Paper | ScholarLens